Published in Cancer Weekly, March 20th, 2001
"The aim of this study was to examine whether the human AFP enhancer could be used to induce hepatocellular carcinoma (HCC)-selective expression of the herpes simplex virus thymidine kinase (HSV-tk) gene, which is under the control of the phosphoglycerate kinase (pgk) promotor," said G. Cao and colleagues.
The researchers linked...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.